Form 4: Marimed COO Timothy Shaw Boosts Stake

Marimed Inc. Chief Operating Officer Timothy Shaw reported recent transactions, including a direct purchase of common stock and the conversion of restricted stock units.

Summary

• Timothy Shaw, Chief Operating Officer of Marimed Inc. (MRMD), reported changes in his beneficial ownership of the company's common stock.
• On December 12, 2025, Mr. Shaw directly acquired 45,455 shares of common stock at a price of $0.1071 per share.
• On December 15, 2025, 81,772 Restricted Stock Units (RSUs) converted into an equal number of common stock shares, with a deemed acquisition price of $0.
• Also on December 15, 2025, 24,001 shares of common stock were disposed of at $0.1071 to satisfy tax withholding obligations related to the RSU vesting.
• Following these transactions, Mr. Shaw directly beneficially owns 9,294,541 shares of common stock.
• Additionally, 2,000,000 shares of common stock are indirectly beneficially owned by The Shaw Family Trust, for which Mr. Shaw disclaims beneficial ownership for Section 16 purposes.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the Chief Operating Officer's direct purchase of company stock, which typically signals confidence. The RSU conversion is a standard compensation event, and the tax withholding is a routine consequence of vesting.

Positives

• Chief Operating Officer Timothy Shaw directly purchased 45,455 shares of common stock, indicating management confidence in the company's future.
• The vesting and conversion of 81,772 Restricted Stock Units (RSUs) represent a form of equity compensation, aligning management's interests with shareholders.

Negatives

• 24,001 shares of common stock were withheld by the Issuer to cover tax withholding obligations related to the RSU vesting, reducing the direct share count.

Future Outlook

NA

Industry Context

This filing is a standard insider transaction report and does not provide broader industry context or trends. However, insider purchases can be viewed as a positive signal within the industry, suggesting confidence in the company's prospects relative to its peers.

Related Party Transactions

• 2,000,000 shares of common stock are indirectly held by The Shaw Family Trust, where the Reporting Person's spouse is the trustee and the shares are for the benefit of the Reporting Person's children. The Reporting Person disclaims beneficial ownership of these securities for Section 16 purposes.

Stakeholder Impact

• Shareholders may view the Chief Operating Officer's direct stock purchase as a positive indicator of management's belief in the company's value and future performance.

Key Dates

Recommendation

The direct purchase of shares by a key executive like the Chief Operating Officer is generally a positive signal, indicating confidence in the company's future. However, a single Form 4 filing, while informative, does not provide sufficient comprehensive financial or strategic data to warrant a 'buy' or 'strong buy' recommendation without further in-depth analysis of the company's fundamentals, market position, and broader industry trends. Therefore, a 'hold' recommendation is appropriate, acknowledging the positive insider sentiment while awaiting more extensive financial disclosures.

Keywords

Marimed, MRMD, Timothy Shaw, Insider Trading, Form 4, Stock Purchase, RSU Conversion, Beneficial Ownership, Chief Operating Officer